OrbiMed’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-9,308,726
| Closed | -$93.5M | – | 129 |
|
|
2023
Q4 | $93.5M | Hold |
9,308,726
| – | – | 1.87% | 14 |
|
|
2023
Q3 | $26.8M | Buy |
9,308,726
+275,000
| +3% | +$792K | 0.57% | 58 |
|
|
2023
Q2 | $34.4M | Sell |
9,033,726
-464,048
| -5% | -$1.77M | 0.62% | 51 |
|
|
2023
Q1 | $17.7M | Buy |
9,497,774
+1,612,904
| +20% | +$3M | 0.35% | 71 |
|
|
2022
Q4 | $18.1M | Hold |
7,884,870
| – | – | 0.35% | 66 |
|
|
2022
Q3 | $25.4K | Hold |
7,884,870
| – | – | 0.47% | 64 |
|
|
2022
Q2 | $43.4K | Hold |
7,884,870
| – | – | 0.79% | 42 |
|
|
2022
Q1 | $18.4M | Hold |
7,884,870
| – | – | 0.3% | 69 |
|
|
2021
Q4 | $47.6M | Hold |
7,884,870
| – | – | 0.61% | 50 |
|
|
2021
Q3 | $109M | Hold |
7,884,870
| – | – | 1.2% | 26 |
|
|
2021
Q2 | $103M | Hold |
7,884,870
| – | – | 1.04% | 31 |
|
|
2021
Q1 | $121M | Buy |
+7,884,870
| New | +$121M | 1.14% | 26 |
|